Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemia

Lancet. 2024 Sep 28;404(10459):1253-1254. doi: 10.1016/S0140-6736(24)01826-9.

¹ Division of Haematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada. Electronic address: [email protected].
² Division of Haematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
³ Division of Haematopathology, Department of Pathology, Dalhousie University, Halifax, NS, Canada.
⁴ Division of Haematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada; Division of Haematology, Department of Medicine, Vancouver, BC, Canada.

No abstract available

Publication types